2024-10-13 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis

**Company Overview:** Abbott Laboratories is a global healthcare company that develops, manufactures, and markets a wide range of products, including pharmaceuticals, medical devices, nutritionals, and diagnostics.

**Performance Analysis:**

1. **Performance vs. S&P 500:**
    * ABT's cumulative return is 107.9%, while the S&P 500 (VOO) has returned 135.82%.
    * ABT is currently lagging behind the S&P 500 by -27.92%, with a relative divergence of 14.34% (meaning it's currently positioned within the 14.34th percentile of its historical performance compared to the S&P 500).

2. **Recent Price Movements:**
    * Closing Price: $116.12
    * 5-Day Moving Average: $115.18
    * 20-Day Moving Average: $114.29
    * 60-Day Moving Average: $111.81
    *  ABT is trading slightly above its 5-day and 20-day moving averages, indicating a potential short-term uptrend. However, the price is below the 60-day moving average, which could suggest some short-term volatility.

3. **Technical Indicators:**
    * **RSI:** 56.77, indicating a moderately overbought condition.
    * **PPO:** 0.13, suggesting a potential bullish signal.
    * **Delta_Previous_Relative_Divergence:** -5.86, indicating a slight short-term downtrend.
    * **Expected Return:** 0.0%, meaning there is no expected return on investment within the next 5 years, given the current market trends and compared to the S&P 500.

4. **Recent Earnings and Outlook:**
    * **Last Earnings Report:** July 31, 2024
    * **EPS:** $0.74
    * **Revenue:** $10.38 Billion
    * **Analyst Estimates:**  (Please provide analyst estimates for the last earnings report for a complete analysis.)
    * Abbott Laboratories has consistently shown strong financial performance, and it is expected to continue its growth trajectory driven by its diverse product portfolio and strong brand presence.

5. **News and Recent Issues:**
    * (Please provide recent news and relevant information regarding ABT, including analyst opinions and performance highlights, ideally sourced from reputable sources like FINBOLD.)

**Overall Analysis:**

Abbott Laboratories has consistently delivered solid performance, but currently, it is lagging behind the market benchmark, the S&P 500. The recent price action suggests potential short-term volatility. However, technical indicators suggest a potential bullish bias. The company has a strong track record of earnings and a solid financial foundation. 

Overall, ABT presents an attractive investment opportunity with potential for growth.  However, it's crucial to consider the current market volatility and monitor the company's performance closely for any significant developments. Investors should conduct thorough research and consult with a financial advisor to determine if ABT aligns with their investment goals and risk tolerance. 
